Stroke is the second largest cause of death globally, claiming an estimated 5.5 million lives annually. The burden of stroke is expected to worsen in the future as a result of demographic and lifestyle changes in developed and developing countries. During the acute stage there are several pharmaceuticals and surgical procedures available to assist healthcare providers manage stroke patients. This market research report provides forecasts and analysis of the embolization products used in the management and treatment of stroke. In addition to market forecasts, this report provides insights into the leading competitors in the cerebral embolization products market.
Neurostimulation devices are utilized to restore function and re-normalize the circuiting of the nervous system in neurological conditions such as drug-refractory epilepsy, major depressive disorder, post-stroke extremity dysfunction, as well as Alzheimer’s and Parkinson’s disease. Globally, neurological conditions affect hundreds of millions of people.
This post in LSI’s series on healthcare and surgical procedure volumes will take a look at healthcare in in the final member of the BRIC, Russia.
The ambitious goal for healthcare in Brazil is “health for all”. Formed in 1988, Brazil’s Sistema Único da Saúde (SUS) is one of the largest public health systems in the world. Universal healthcare in Brazil is funded through local and federal taxes provided by government and private institutions. The SUS ensures that Brazilian residents and foreigners in Brazil have access to public healthcare. It is estimated that 75% of Brazil’s 200+ million residents is reliant on the SUS for access to healthcare.
Japan boasts one of the best healthcare systems in the world. According to Zhang and Oyama, the success of the Japanese healthcare system can be attributed to policy-makers that have diligently balanced and controlled prices within the countries universal healthcare system. The quality of medical treatment in Japan is competitive with that quality of treatment received in the US.
In our last few posts, we’ve been giving you reasons to attend Emerging Medtech Summit 2020. This industry-leading conference, hosted by Life Science Intelligence, will be held February 18th through the 20th in Dana Point, California, at The Ritz-Carlton Laguna Niguel.
Canada’s healthcare system has been touted and adored by some of the country’s southern neighbors for years. Compared to the “hands-off” approach to healthcare demonstrated by the US government, healthcare in Canada has been highly regulated in an attempt to control costs. Canadian life expectancy has continued to improve in the last two decades, in part due to access to advanced healthcare therapies and pharmaceuticals as is common in Western countries.
Chronic pain places a tremendous burden on the global healthcare system. It is estimated that in the US alone, chronic pain and high-impact chronic pain affect nearly 30% of US adults. The economic costs of chronic pain are equally immense in the US, with estimates suggesting that chronic pain costs range from $500-600 billion annually in direct and indirect costs. As addiction to opioids has reached crisis levels in the US, and threatens to spread to other nations, there is significant opportunity for therapies that can help patients live with chronic pain without relying on addictive pain medication. Neurostimulation is one such modality that are helping people manage chronic pain.
With a massive population exceeding 1.3 billion people, the healthcare system in India is tasked with providing care to the large rural and urban areas of the country. The dichotomy between quality of care in rural and urban is one of, if not the largest challenges that India’s healthcare system faces. The contrast between quality of care in India’s rural and urban areas, as well as India’s status as a developing nation has resulted in initiatives aimed at elevating quality of care and access to healthcare.
Healthcare in Europe parallels the US healthcare system in many ways. Western Europe faces significant challenges when it comes to determining how to efficiently meet the demand for more healthcare to an aging population with an increasing burden of age-related chronic diseases. Simultaneously, the issues of how to keep costs down and affordable to patients continues to test the healthcare sector in the five major European markets (France, Germany, Italy, Spain, United Kingdom). However, these problems are not unique to the five largest economies in Europe. These challenges pervade all countries within the European Union.